title: Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333.
abstract: Three applications from Boehringer Ingelheim all relate to the preparation of non-steroidal glucocorticoid receptor agonists useful in the treatment of inflammatory respiratory diseases. The first two applications claim chiral processes for the preparation of these compounds or intermediates useful therein. These provide two alternative routes, respectively, using achiral and chiral reagents. The third application relates to the preparation of a crystalline salt of the preferred compound on a multi-kilogram scale in micronised form.
authors.affiliation: Norman Consulting, 18 Pink Lane, Burnham, Bucks, SL1 8JW, UK. petrosn@bigfoot.com
authors.forename: Peter
authors.initials: P
authors.lastname: Norman
mesh_terms: D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D003460:Crystallization; D015195:Drug Design; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D010330:Patents as Topic; D011965:Receptors, Glucocorticoid / Q000819:agonists*; D012140:Respiratory Tract Diseases / Q000188:drug therapy* / Q000503:physiopathology; D012492:Salts; D013237:Stereoisomerism
chemical_list: D000893:Anti-Inflammatory Agents; D011965:Receptors, Glucocorticoid; D012492:Salts